Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke-Reference-Cited by-同舟云学术

Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke

Published:2013-09 Issue: Volume:62 Page:26-36
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Speer Rachel E.,Karuppagounder Saravanan S.,Basso Manuela,Sleiman Sama F.,Kumar Amit,Brand David,Smirnova Natalya,Gazaryan Irina,Khim Soah J.,Ratan Rajiv R.

Funder

NYS DOH C019772 (R.R.R.), the Thomas Hartman Foundation (R.R.R), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (R.R.R), and the Burke Foundation

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference140 articles.

1. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell,2012

2. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons;Ryu;J. Neurosci.,2003

3. ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo;Lange;J. Exp. Med.,2008

4. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway;Ryu;Proc. Natl. Acad. Sci. USA,2003

5. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system;Siddiq;J. Biol. Chem.,2005

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia and ferroptosis;Cellular Signalling;2024-10

2. A nature-inspired HIF stabilizer derived from a highland-adaptation insertion of plateau pika Epas1 protein;Cell Reports;2024-09

3. Molecular Docking and Dynamic Simulation Studies of PHD2 Interactions with Gut Siderophores: Implications for HIF-1α Stabilization;2024-08-09

4. Ferroptosis: Implications in Diseases and Potential Treatment Approaches;Biosciences Biotechnology Research Asia;2024-07-01

5. Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol;BMC Neurology;2024-06-22